Incannex Healthcare Inc. (ticker: IXHL) is an NASDAQ-listed pharma company. DredgeCap's structured extraction of IXHL's SEC filings surfaces 3 active risk signals, including 2 delisting/deregistration signals, and 1 auditor-change signal. IXHL reported $86K in revenue and -$12.93M for the period ending 2025-03-31, with operating cash flow of -$13.79M. Cash and equivalents stood at $68.90M (up 3184.1% year-over-year). Total assets of $75.01M exceed total liabilities of $1.60M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
IXHL Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for Incannex Healthcare Inc. (IXHL) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.